Opus Genetics Inc
NASDAQ:IRD

Watchlist Manager
Opus Genetics Inc Logo
Opus Genetics Inc
NASDAQ:IRD
Watchlist
Price: 2.11 USD 1.44% Market Closed
Market Cap: 145.5m USD

Relative Value

The Relative Value of one IRD stock under the Base Case scenario is hidden USD. Compared to the current market price of 2.11 USD, Opus Genetics Inc is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

IRD Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
15
vs Industry
29
Median 3Y
3
Median 5Y
3
Industry
2.6
Forward
10.1
vs History
vs Industry
Median 3Y
-1.1
Median 5Y
-1.2
Industry
21.4
Forward
-2.9
vs History
vs Industry
Median 3Y
-2
Median 5Y
-2.4
Industry
16.4
vs History
vs Industry
Median 3Y
-2.1
Median 5Y
-2.4
Industry
22.8
vs History
1
vs Industry
60
Median 3Y
1.6
Median 5Y
2.3
Industry
2.2
vs History
15
vs Industry
Median 3Y
0.7
Median 5Y
0.5
Industry
2.9
Forward
7.9
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
5.5
vs History
vs Industry
58
Median 3Y
0
Median 5Y
-1
Industry
13
Forward
12.1
vs History
vs Industry
55
Median 3Y
0
Median 5Y
-1
Industry
16.5
Forward
-2.9
vs History
vs Industry
59
Median 3Y
0
Median 5Y
-1.1
Industry
15.6
vs History
vs Industry
46
Median 3Y
0
Median 5Y
-1.1
Industry
18.7
vs History
15
vs Industry
Median 3Y
5.2
Median 5Y
2.1
Industry
1.9

Multiples Across Competitors

IRD Competitors Multiples
Opus Genetics Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Opus Genetics Inc
NASDAQ:IRD
136.2m USD 9.3 -2 -3.1 -3.1
US
Eli Lilly and Co
NYSE:LLY
1T USD 17.6 56.9 38.1 40.9
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
499.3B USD 5.4 19.9 16.3 21.1
CH
Roche Holding AG
SIX:ROG
269.9B CHF 4.4 28.6 12.2 14.2
UK
AstraZeneca PLC
LSE:AZN
220.3B GBP 5.1 31.5 108.7 159.2
US
Merck & Co Inc
NYSE:MRK
270.1B USD 4.2 14.2 10.1 11.9
CH
Novartis AG
SIX:NOVN
218.4B CHF 4.9 19 12 15.5
DK
Novo Nordisk A/S
CSE:NOVO B
1.6T DKK 5.1 15.6 10.9 12.7
IE
Endo International PLC
LSE:0Y5F
213.9B USD 92.2 -73.2 338.7 849.2
US
Pfizer Inc
NYSE:PFE
143.7B USD 2.3 14.6 7.5 10.2
P/E Multiple
Earnings Growth PEG
US
Opus Genetics Inc
NASDAQ:IRD
Average P/E: 25.1
Negative Multiple: -2
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
56.9
54%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
19.9
29%
0.7
CH
Roche Holding AG
SIX:ROG
28.6
29%
1
UK
AstraZeneca PLC
LSE:AZN
31.5
37%
0.9
US
Merck & Co Inc
NYSE:MRK
14.2
15%
0.9
CH
Novartis AG
SIX:NOVN
19
17%
1.1
DK
Novo Nordisk A/S
CSE:NOVO B
15.6
3%
5.2
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -73.2 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.6
27%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Opus Genetics Inc
NASDAQ:IRD
Average EV/EBITDA: 440.1
Negative Multiple: -3.1
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
38.1
34%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16.3
9%
1.8
CH
Roche Holding AG
SIX:ROG
12.2
5%
2.4
UK
AstraZeneca PLC
LSE:AZN
108.7
10%
10.9
US
Merck & Co Inc
NYSE:MRK
10.1
6%
1.7
CH
Novartis AG
SIX:NOVN
12
6%
2
DK
Novo Nordisk A/S
CSE:NOVO B
10.9
1%
10.9
IE
E
Endo International PLC
LSE:0Y5F
338.7
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.5
0%
N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Opus Genetics Inc
NASDAQ:IRD
Average EV/EBIT: 1 883.7
Negative Multiple: -3.1
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
40.9
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
21.1
15%
1.4
CH
Roche Holding AG
SIX:ROG
14.2
6%
2.4
UK
AstraZeneca PLC
LSE:AZN
159.2
23%
6.9
US
Merck & Co Inc
NYSE:MRK
11.9
8%
1.5
CH
Novartis AG
SIX:NOVN
15.5
12%
1.3
DK
Novo Nordisk A/S
CSE:NOVO B
12.7
0%
N/A
IE
E
Endo International PLC
LSE:0Y5F
849.2
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.2
7%
1.5